- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 16, 2026 | 31.93M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 10.52M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2025 | 4.97M sh |
| Capex | Q1 2026 · Jan 31, 2026 | $55.1K |
| Capex | Q1 2026 · Jan 31, 2025 | $78.17K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$533.89K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | −$920.49K |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $12.19M |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $11.3M |
| Stockholders Equity | Q1 2026 · Jan 31, 2025 | $11.69M |
| Stockholders Equity | Q1 2026 · Oct 31, 2024 | $9.04M |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $1.8M |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $1.86M |
| Total Liabilities | Q1 2026 · Jan 31, 2026 | $1.97M |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $1.91M |
| Current Assets | Q1 2026 · Jan 31, 2026 | $902.54K |
| Current Assets | Q1 2026 · Oct 31, 2025 | $1.07M |
| Total Assets | Q1 2026 · Jan 31, 2026 | $14.17M |
| Total Assets | Q1 2026 · Oct 31, 2025 | $13.21M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.10 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | −$0.33 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.10 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | −$0.33 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $751.82K |
| Sga Expense | Q1 2026 · Jan 31, 2025 | $711.55K |
| Net Income | Q1 2026 · Jan 31, 2026 | −$1.01M |
| Net Income | Q1 2026 · Jan 31, 2025 | −$1.62M |
| Operating Income | Q1 2026 · Jan 31, 2026 | −$804.39K |
| Operating Income | Q1 2026 · Jan 31, 2025 | −$1.22M |
| Gross Profit | Q1 2026 · Jan 31, 2026 | $53.79K |
| Gross Profit | Q1 2026 · Jan 31, 2025 | $10.82K |
| Cost Of Revenue | Q1 2026 · Jan 31, 2026 | $68.4K |
| Revenue | Q1 2026 · Jan 31, 2026 | $122.19K |
| Revenue | Q1 2026 · Jan 31, 2025 | $10.82K |